BioSpace News Archive

Cigna has named Noelle Eder, Global Chief Information Officer, effective September 14. She will report to David M. Cordani, President and Chief Executive Officer and will serve as a member of the Enterprise Leadership Team.

Swittons, a P360 company, has announced a new line of Internet of Things (IoT) enabled smart devices built specifically for pharmaceutical labs.

Sinclair Research, a leading provider of nonclinical research services, has named Dr. Tina Rogers, PhD, MBA, DABT as Senior Scientific Advisor.

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at The JMP Securities CNS Forum on Wednesday, August 19, 2020, at 11:00 a.m. Eastern Time. The conference will be held virtually. A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.acadia-pharm.com , under the investors section and an archived recording will be available on the website through September 1

Landmark Cell Publication Reveals Novel Spatial Biology Discoveries Enabled by the CODEX® Platform New peer-reviewed paper outlines novel organizing principles and spatial interactions between “neighborhoods” of cells in the tumor microenvironment of colorectal cancer. MENLO PARK, Calif.--( BUSINESS WIRE )-- Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the application of the CODEX® platform to a recent Cell publication ti

Trevena, Inc. (Nasdaq: TRVN) (“Trevena” or the “Company”), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (“CNS”) disorders, announced today the pricing of its previously announced underwritten public offering of 21,739,131 shares of its common stock at a public offering price of $2.30 per share. Trevena has also granted the underwriters a 30-day opti

Echosens, a high-technology company offering the FibroScan family of products, points to the critical importance of new guidelines issued jointly by the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF), which include a detailed discussion and recommendations to assist prescribers on the efficacy and safety for the most commonly prescribed medications for psoriasis

Join us on August 19 at 3:00 PM ET as the Christopher & Dana Reeve Foundation Paralysis Resource Center (PRC) hosts Living Well with Dr. John- Adjustment through the lifespan

MJH Life Sciences™ confirmed today that all conferences, satellite symposia, award programs and educational programming produced by the privately owned health care media company will take place in virtual format through March 2021.

Today, the U.S. Food and Drug Administration granted accelerated approval to Viltepso (viltolarsen) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.